University of Nevada, Reno
If you have any problems related to the accessibility of any content (or if you want to request that a specific publication be accessible), please contact us at scholarworks@unr.edu.
| Author | Kohlenberg, Barbara S. | |
| Author | Antonuccio, David O. | |
| Author | Hayes, Steven C. | |
| Author | Gifford, Elizabeth V. | |
| Author | Piasecki, Melissa P. | |
| Date Accessioned | 2016-11-29T18:57:15Z | |
| Date Available | 2016-11-29T18:57:15Z | |
| Date of Issue | 2004 | |
| ISSN | 0033-3190 | |
| Identifier (URI) | http://hdl.handle.net/11714/204 | |
| Description | Background: Bupropion SR ( Zyban) has been shown in randomized controlled trials to be an efficacious pharmacological aid for smoking cessation; however, recent reports have raised serious concerns about the breadth of its applicability without complications or contraindications. Methods: We examined this issue in a well-documented medical population, i.e. veterans volunteering to participate in a smoking cessation treatment research program involving the use of bupropion SR. Results: Overall, 22% of the 78 subjects who met the study criteria were appropriate for and completed the course of medication. Conclusions: Thus, bupropion SR in nicotine-dependent veterans may not be broadly applicable when conservative prescribing guidelines are carefully followed. Copyright (C) 2004 S. Karger AG, Basel. | |
| Item Language | en_US | |
| Rights | In Copyright | |
| Source URI | https://dx.doi.org/10.1159/000077744 | |
| Subject | bupropion sr
| |
| Subject | contraindications
| |
| Subject | nicotine dependence
| |
| Subject | smoking cessation
| |
| Title | Suitability of Bupropion SR for nicotine-dependent smokers: Problems in a practice setting | |
| Type | Citation | |
| Identifier (DOI) | 10.1159/000077744 |
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||